Key result
IVC filter occlusion and marked collaterals develop despite therapeutic anticoagulation in a CTEPH and APS patient.
Why the study?
The development of marked collateral circulation due to inferior vena cava filter occlusion in patients with CTEPH and lupus anticoagulants is rarely reported and may require intense treatment.
Case Report (n=1)
No
Patients with CTEPH and lupus anticoagulants may develop IVCF occlusion despite therapeutic warfarin levels, suggesting a need for more intense treatment.
Answers are grounded in this paper and cite their sources.
IVCF occlusion may occur despite therapeutic anticoagulation in CTEPH with APS; hypothesis-generating for intensified regimens or alternatives in future studies.
A 30-year-old Japanese man was diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH) with lupus anticoagulants (LAs) in 2003. He underwent pulmonary endarterectomy after the placement of an inferior vena cava filter (IVCF) in 2004, and treatment with warfarin was continued. In 2014, IVCF occlusion and marked collateral circulation were noted during an examination for transient dyspnea; however, his warfarin level was within the therapeutic range for 88.9% of the time from 2003 to 2014. We herein report a rare case of CTEPH and LAs with IVCF occlusion; in such cases, intense treatment may be required.
No takes yet. Share an insight, caveat, or question.
Kasai et al. (2017) conducted a case report in Chronic thromboembolic pulmonary hypertension (CTEPH) and anti-phospholipid syndrome (APS) (n=1). Inferior vena cava filter (IVCF) placement was evaluated on Development of IVCF occlusion and collateral circulation. A patient with chronic thromboembolic pulmonary hypertension and anti-phospholipid syndrome developed complete inferior vena cava filter occlusion and marked collateral circulation despite therapeutic anticoagulation.
Synapse has enriched 10 related papers. Consider them for comparative context: